COMMUNIQUÉS West-GlobeNewswire

Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome
28/07/2026
Expanded panel advances the understanding of immune system across translational and clinical research in cancer, cardiovascular and metabolic diseases, autoimmune diseases and aging Highly sensitive multiplex [...]
Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome
28/07/2026
Expanded panel advances the understanding of immune system across translational and clinical research in cancer, cardiovascular and metabolic diseases, autoimmune diseases and aging | Highly sensitive multiplex [...]
Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11
28/07/2026
ROMEOVILLE, Ill., July 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company [...]
Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference
28/07/2026
SUNNYVALE, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
28/07/2026
HIGH POINT, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin , a novel, potential first-in-class oral [...]
PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference
28/07/2026
MENLO PARK, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat [...]
Jushi Holdings Inc. Reports Second Quarter 2026 Financial Results
28/07/2026
Revenue Increased 10% Year-over-Year to $71.3 million , Reflecting Growth Across Both Retail and Wholesale Channels Wholesale Revenue Increased 68% to an All-Time Quarterly Record of $9.4 Million Record Quarterly [...]
Ultragenyx to Host Conference Call for Second Quarter 2026 Financial Results and Corporate Update
28/07/2026
NOVATO, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra- [...]
Tilray Brands Delivers Record Fiscal 2026 Revenue and Adjusted EBITDA; Demonstrating the Strength of its Diversified Global Platform Across Cannabis, Beverage, Hospitality and Wellness
28/07/2026
Record Fiscal Year Net Revenue of $ 915 Million, Record Gross Profit, Consistent Adjusted Gross Margin 3 and Record Adjusted EBITDA 5 Highlights the Strength of Tilray’s Scaled Businesses and Profitable Growth Strategy [...]
Kymera Therapeutics to Report Second Quarter 2026 Financial Results on August 5, 2026
28/07/2026
WATERTOWN, Mass., July 28, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological [...]
Acquisition of Own Shares
28/07/2026
Mechelen, Belgium; July 28, 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Ocugen to Host Conference Call on Thursday, August 6 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2026 Financial Results
28/07/2026
MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a [...]
MannKind to Report Second Quarter Financial Results and Host Conference Call on August 5, 2026
28/07/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , today announced that the Company will report second quarter 2026 financial results after market close [...]
National Center for Cannabis Research and Education at the University of Mississippi and Southern Sky Brands Launch CBD Sleep Study
28/07/2026
OXFORD, Miss. and CANTON, Miss., July 28, 2026 (GLOBE NEWSWIRE) -- The National Center for Cannabis Research and Education (NCCRE) at the University of Mississippi and Southern Sky Brands have announced a collaborative [...]
The Cooperative of American Physicians Promotes Simon Russell to Vice President of Underwriting
28/07/2026
LOS ANGELES, July 28, 2026 (GLOBE NEWSWIRE) -- The Cooperative of American Physicians, Inc. (CAP), a leading provider of medical malpractice coverage, announced the promotion of Simon Russell to Vice President of [...]
Healthcare Executives Signal Growing Strategic Value of Laboratory Services, Siemens Healthineers Survey Finds
28/07/2026
New research indicates attention on laboratory modernization. As the Association for Diagnostics and Laboratory Medicine 2026 Annual Scientific Meeting and Clinical Lab Expo kicks off, Siemens Healthineers will unveil [...]
Pennant Announces Second Quarter 2026 Earnings Release and Call
28/07/2026
EAGLE, Idaho, July 28, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it [...]
AscellaHealth Appoints Industry Veteran Johanna van Nijkerk as Vice President of Business Development to Advance National Accounts and Drive Growth of AscellaOne
28/07/2026
BERWYN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- AscellaHealth , a full-spectrum pharmacy solutions provider rooted in specialty pharmacy expertise, today announces the appointment of Johanna van Nijkerk as vice president [...]
RECORDATI: SOLID MOMENTUM OF THE GROUP CONTINUES FIRST HALF 2026. NET REVENUE +6.6%, EBITDA +8.8%, ADJUSTED NET INCOME +6.7%
28/07/2026
Consolidated net revenue of € 1,410.8 million in the first half of 2026, +6.6% or +9.1% on a like-for-like basis ( 3) at constant exchange rates (CER); adverse FX impact of € 34.5 million (-2.6%) EBITDA ( 1) of € 540.2 [...]

Pages